Koshinski Asset Management
ASND icon

Koshinski Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Koshinski Asset Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44
Closed -$7.01K – 2153
2021
Q3 		$7.01K Buy
+44
New +$6.02K ﹤0.01% 1750

Other funds holding ASND

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Koshinski Asset Management's ASND Position: Q4 2021 in Review

Koshinski Asset Management sold out of Ascendis Pharma A/S (ASND) in Q4 2021, closing a stake of 44 shares — an estimated $7.01K sold.

Koshinski Asset Management first reported a position in ASND in Q3 2021 and held it in 1 quarter. The position peaked at $7.01K in Q3 2021. 172 funds tracked by Wall St. Rank hold ASND as of Q4 2021.

  • Koshinski Asset Management reported no remaining Ascendis Pharma A/S position as of Q4 2021 after selling out during the quarter.
  • Koshinski Asset Management sold 44 Ascendis Pharma A/S shares in Q4 2021, an estimated $7.01K.
  • Koshinski Asset Management first reported a position in Ascendis Pharma A/S in Q3 2021 and held it in 1 quarter.
  • Koshinski Asset Management's Ascendis Pharma A/S position peaked at $7.01K in Q3 2021.
  • 172 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2021.

Based on Koshinski Asset Management's 13F filing for Q4 2021, filed 14 Jan 2022.